Neutral impactStocks
Nifty 500: Mankind Pharma, Sona BLW rally; Aequs plunges 18%, two stocks hit 52-week lows on Q2 results
CNBC TV18 56 min ago·27 Oct 2026, 4:47 am
Mankind Pharma and Sona BLW Technologies saw their shares rise significantly after their latest quarterly earnings report. The rally in these stocks suggests that investors are reacting positively to the companies' strong operational performance and growth prospects.
The sharp decline in Aequs, however, highlights the volatility that can accompany quarterly results. The stock's drop to a new 52-week low indicates that the company may have missed market expectations or faced challenges in its recent business segment.
Investors should keep a close watch on the broader market reaction to these results. While strong performers like Mankind and Sona BLW may offer stability, the drop in Aequs serves as a reminder to evaluate individual company fundamentals before making any investment decisions.
Excerpt from CNBC TV18
Published On Oct 27, 2026 | 10:17 IST Last Updated On Oct 27, 2026 | 10:17 IST Sona BLW and Mankind Pharma gain over 7% each after strong Q2 results, while Aequs tumbles as its net loss widens. Sumitomo Chemical India and Dalmia Bharat hit fresh 52-week lows. Sona BLW Precision Forgings and Mankind Pharma were the…Read the original at CNBC TV18
Affected stocks
Neutral2 stocks
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Mankind Pharma (MANKIND).
- Category: Stocks.
- Assessed as a significant, market-relevant update.
- Also mentions SONACOMS.
Why it matters
A meaningful update for Mankind Pharma worth tracking. Use the price and stock snapshot to gauge how the market is responding.
